Melanoma: open trials in Israel

13 open trials have a site in Israel. Registry data; only the trial team decides who can take part.

NCT06697301
Safety and Efficacy of EIK1001 in Combo With Pembro Versus Placebo and Pembro as First-Line Therapy in Patients With Advanced Melanoma.
Trial Treatment · Phase 2/3 · Eikon Therapeutics
Soroka Medical Center, Beersheba · Rabin Medical Center, Petah Tikva · Ella Lemelbaum Institute for Immuno-Oncology and Melanoma, Ramat Gan · Tel Aviv Medical Center, Tel Aviv
Registry updated 2026-10-06
NCT06961006
A Clinical Study of Intismeran Autogene (V940) and Pembrolizumab (MK-3475) in People With Melanoma (V940-012/INTerpath-012)
Trial Treatment · Phase 2 · Merck Sharp & Dohme LLC
HaEmek Medical Center ( Site 3003), Afula · Hadassah Medical Center ( Site 3001), Jerusalem · Rabin Medical Center ( Site 3002), Petah Tikva · Sheba Medical Center ( Site 3000), Ramat Gan
Registry updated 2026-09-28
NCT05727904
Study to Investigate Lifileucel Regimen Plus Pembrolizumab Compared With Pembrolizumab Alone in Participants With Untreated Advanced Melanoma.
Trial Treatment · Phase 3 · Iovance Biotherapeutics, Inc.
Hadassah medical Center, Jerusalem · Sheba medical center, Ramat Gan · Tel-Aviv Sourasky Medical Center, Tel Aviv
Registry updated 2026-09-24
NCT04895709
A Study of BMS-986340 as Monotherapy and as Combination Therapy in Participants With Advanced Solid Tumors
Trial Treatment · Phase 1/2 · Bristol-Myers Squibb
Rambam Health Care Campus, Haifa · Rabin Medical Center, Petah Tikva · Sheba medical center, Ramat Gan · Ramat Gan · Sourasky Medical Center, Tel Aviv
Registry updated 2026-08-17
NCT02332668
A Study of Pembrolizumab (MK-3475) in Pediatric Participants With an Advanced Solid Tumor or Lymphoma (MK-3475-051/KEYNOTE-051)
Trial Treatment · Phase 1/2 · Merck Sharp & Dohme LLC
Merck Sharp & Dohme Co. Ltd., Hod HaSharon
Registry updated 2026-07-06
NCT07049276
The Multicentre Selective Lymphadenectomy Trial - 3
Trial Treatment · Melanoma Institute Australia
Sheba Medical Centre, Ramat Gan
Registry updated 2026-06-29
NCT07015190
Neoadjuvant Darovasertib in Primary Uveal Melanoma
Trial Treatment · Phase 3 · IDEAYA Biosciences
Hadassah Medical Center PPDS -, Jerusalem · The Chaim Sheba Medical Center - PPDS, Ramat Gan
Registry updated 2026-05-06
NCT00722228
Autologous and Allogeneic Whole Cell Cancer Vaccine for Metastatic Tumors
Trial Treatment · Phase 1/2 · Hadassah Medical Organization
Hadassah Medical Organization, Jerusalem
Registry updated 2025-10-02
NCT01898039
Modified Vaccine for High Risk or Low Residual Melanoma Patients
Trial Treatment · Phase 1/2 · Hadassah Medical Organization
Sharett Institute of Oncology, Hadassah Medical Organization, Jerusalem
Registry updated 2025-10-02
NCT05296564
Anti-NY-ESO-1 TCR-Gene Engineered Lymphocytes Given by Infusion to Patients With NY-ESO-1 -Expressing Metastatic Cancers
Trial Treatment · Phase 1/2 · Hadassah Medical Organization
Hadassah Medical Organization, Jerusalem
Registry updated 2025-10-02
NCT05909618
Crizanlizumab Alone or in Combination With Nivolumab for Glioblastoma and Melanoma With Brain Metastases
Trial Treatment · Phase 2 · Sheba Medical Center
Sheba medical center, Ramat Gan
Registry updated 2025-07-22
NCT06896552
Single-Center Trial on Ketogenic Diet and Immunotherapy in Advanced Cancer This Study Evaluates the Safety and Effects of a Ketogenic Diet (KD) Combined With Immunotherapy in Adults With Advanced Melanoma, cSCC, or RCC.
Trial Treatment · Phase 1/2 · Rabin Medical Center
Rabin Medical Center, Petah Tikva
Registry updated 2025-03-26
NCT01438658
Assessing the Clinical Effectiveness of Serum Biomarkers in the Diagnosis of Metastatic Uveal Melanoma
Research · Hadassah Medical Organization
Specialized Ocular Oncology Service, Hadassah-Hebrew-University Medical Center, Jerusalem
Registry updated 2011-09-28

All Melanoma trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error